The Role of Patient Experience Data in Drug Development with Pina Haberl and Sam Morrison

Rare Disease, Cell & Gene Therapy Monthly RoundUp by Partners4Access

May 3, 202400:34:37Science & Medicine

Welcome to this month's episode of the P4A Let’s Talk Rare podcast by Partners4Acess. Today, Georgie and Owen are joined by their colleagues Pina Haberl , Senior Director, and Sam Morrison , Executive Director at Partner...

Related Episodes

Continue listening to more episodes from Rare Disease, Cell & Gene Therapy Monthly RoundUp.

Solving Patient Matching in Rare Disease Trials

Apr 29, 2026 - 00:33:36

One of the most persistent barriers in rare disease drug development isn’t the science — it’s identifying...

Rare Disease Day Special: The stats and stories you need to hear.

Feb 27, 2026 - 00:32:20

Rare Disease Day Special | Let’s Talk Rare This Rare Disease Day, Let’s Talk Rare releases a special epis...

2026 Trends: A Year Of Change & Opportunity

Jan 30, 2026 - 00:17:08

26 isn’t just another year in market access — it’s a turning point. In this episode of Let’s Talk Rare ,...

Going To Glasgow: ISPOR 2025

Dec 2, 2025 - 00:22:15

In this episode of Let’s Talk Rare , we looked back at P4A’s recent trip to Glasgow, where our colleagues...

Conversations Beyond the Clinic

Nov 3, 2025 - 00:26:18

Recorded live from ESMO 2025, Conversations Beyond the Clinic explores the different perspectives of the...

Voices Uncovered: Understanding Mental Health in Rare Diseases using Social Listening

Sep 29, 2025 - 00:30:05

In this episode, we tune into the unfiltered voices of patients and caregivers navigating life with rare...

Stronger Together: Collaborating for Better Patient Information with Catherine Richards Golini

Aug 26, 2025 - 00:33:16

How do we make sure patients receive health information that is clear, trustworthy, and truly helpful? We...

OST-HER2 and the Fight Against Osteosarcoma: A New Hope After 40 Years

Jul 1, 2025 - 00:27:44

Join us as we sit down with Paul Romness of OS Therapies to explore an exciting breakthrough in OST-HER2...